The total return over the past 12 months is -39.33% vs. +16.94% for the S&P 500. So far it's up -30.51% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (39.33%) | (10.76%) | N/A | N/A | N/A | N/A |
| Total Return CAGR | (39.33%) | (10.76%) | N/A | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Cognition Therapeutics, Inc. (CGTX)
| Year | Start price | End price | CGTX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.35 | $0.94 | (30.51%) | +14.51% | (45.02%) |
| 2025 | $0.70 | $1.35 | +92.50% | +17.72% | +74.78% |
| 2024 | $1.85 | $0.70 | (62.09%) | +24.89% | (86.98%) |
| 2023 | $2.10 | $1.85 | (11.90%) | +26.19% | (38.09%) |
| 2022 | $6.32 | $2.10 | (66.77%) | (18.17%) | (48.60%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
